Find Research Outputs

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Toshihiro Miyamoto
2017

Recurrent subcutaneous sweet’s disease in a myelofibrosis patient treated with ruxolitinib before allogeneic stem cell transplantation

Sakoda, T., Kanamitsu, Y., Mori, Y., Sasaki, K., Yonemitsu, E., Nagae, K., Yoshimoto, G., Kamezaki, K., Kato, K., Takenaka, K., Miyamoto, T., Furue, M., Iwasaki, H. & Akashi, K., Jan 1 2017, In : Internal Medicine. 56, 18, p. 2481-2485 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2019

Usefulness of medication instruction sheets for sharing information on cancer chemotherapy within the health care team

Uchida, M., Nakamura, T., Watanabe, H., Kato, K., Miyamoto, T., Akashi, K. & Masuda, S., Jan 1 2019, In : Pharmazie. 74, 9, p. 566-569 4 p.

Research output: Contribution to journalArticle

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jan 22 2019, In : International journal of hematology. 109, 1, p. 107-114 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2016

Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with KitWv Mutations

Yurino, A., Takenaka, K., Yamauchi, T., Nunomura, T., Uehara, Y., Jinnouchi, F., Miyawaki, K., Kikushige, Y., Kato, K., Miyamoto, T., Iwasaki, H., Kunisaki, Y. & Akashi, K., Sep 13 2016, In : Stem Cell Reports. 7, 3, p. 425-438 14 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)
2019

Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation

For the Fukuoka Blood and Marrow Transplantation Group, Jan 22 2019, In : International journal of hematology. 109, 1, p. 98-106 9 p.

Research output: Contribution to journalArticle

2018
1 Citation (Scopus)

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy

Uchida, M., Nakamura, T., Makihara, Y., Suetsugu, K., Ikesue, H., Mori, Y., Kato, K., Shiratsuchi, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2018, In : Pharmazie. 73, 5, p. 304-308 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2019

Evaluation of the compliance with antiemetic guidelines for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancy

Uchida, M., Nakamura, T., Shima, T., Mori, Y., Yoshimoto, G., Kato, K., Shimokawa, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2019, In : Pharmazie. 74, 4, p. 250-254 5 p.

Research output: Contribution to journalArticle

2017

Identification of unipotent megakaryocyte progenitors in human hematopoiesis

Miyawaki, K., Iwasaki, H., Jiromaru, T., Kusumoto, H., Yurino, A., Sugio, T., Uehara, Y., Odawara, J., Daitoku, S., Kunisaki, Y., Mori, Y., Arinobu, Y., Tsuzuki, H., Kikushige, Y., Iino, T., Kato, K., Takenaka, K., Miyamoto, T., Maeda, T. & Akashi, K., Jun 22 2017, In : Blood. 129, 25, p. 3332-3343 12 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)
2018

Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission

For the Japan Study Group for Cell Therapy and Transplantation (JSCT), Apr 1 2018, In : International journal of hematology. 107, 4, p. 468-477 10 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2019
2 Citations (Scopus)
2018
1 Citation (Scopus)
2016

Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy

Miyamura, K., Miyamoto, T., Tanimoto, M., Yamamoto, K., Kimura, S., Kawaguchi, T., Matsumura, I., Hata, T., Tsurumi, H., Saito, S., Hino, M., Tadokoro, S., Meguro, K., Hyodo, H., Yamamoto, M., Kubo, K., Tsukada, J., Kondo, M., Aoki, M., Okada, H. & 3 others, Yanada, M., Ohyashiki, K. & Taniwaki, M., Dec 1 2016, In : Leukemia Research. 51, p. 11-18 8 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2019

Anti-GPRC5D/CD3 bispecific T-cell-redirecting antibody for the treatment of multiple myeloma

Kodama, T., Kochi, Y., Nakai, W., Mizuno, H., Baba, T., Habu, K., Sawada, N., Tsunoda, H., Shima, T., Miyawaki, K., Kikushige, Y., Mori, Y., Miyamoto, T., Maeda, T. & Akashi, K., Jan 1 2019, In : Molecular Cancer Therapeutics. 18, 9, p. 1555-1564 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Prophylactic antiemetics for haematological malignancies: Prospective nationwide survey subset analysis in Japan

Yoshida, I., Tamura, K., Miyamoto, T., Shimokawa, M., Takamatsu, Y., Nanya, Y., Matsumura, I., Gotoh, M., Igarashi, T., Takahashi, T., Aiba, K., Kumagai, K., Ishizawa, K., Kurita, N., Usui, N. & Hatake, K., Jan 1 2019, In : In Vivo. 33, 4, p. 1355-1362 8 p.

Research output: Contribution to journalArticle

Open Access
2017
3 Citations (Scopus)
2018
2019

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Nagafuji, K., Matsumura, I., Shimose, T., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., Kadowaki, N., Ishikawa, J., Imamura, Y., Yamazaki, H., Akashi, K. & Kanakura, Y., Dec 1 2019, In : International journal of hematology. 110, 6, p. 675-682 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation

HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

2017

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program

Medical Committee of Japan Marrow Donor Program, Japanese Data Center for Hematopoietic Cell Transplantation, Jun 2017, In : Biology of Blood and Marrow Transplantation. 23, 6, p. 938-944 7 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)
2020

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jan 1 2020, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

2017

Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies

Minami, Y., Minami, H., Miyamoto, T., Yoshimoto, G., Kobayashi, Y., Munakata, W., Onishi, Y., Kobayashi, M., Ikuta, M., Chan, G., Woolfson, A., Ono, C., Shaik, M. N., Fujii, Y., Zheng, X. & Naoe, T., Aug 2017, In : Cancer Science. 108, 8, p. 1628-1633 6 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)
2018

Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study

Usuki, K., Sakura, T., Kobayashi, Y., Miyamoto, T., Iida, H., Morita, S., Bahceci, E., Kaneko, M., Kusano, M., Yamada, S., Takeshita, S., Miyawaki, S. & Naoe, T., Oct 2018, In : Cancer Science. 109, 10, p. 3235-3244 10 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS

Sugio, T., Miyawaki, K., Kato, K., Sasaki, K., Yamada, K., Iqbal, J., Miyamoto, T., Ohshima, K., Maeda, T., Miyoshi, H. & Akashi, K., Sep 11 2018, In : Blood Advances. 2, 17, p. 2242-2252 11 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2017

Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response

Yuda, J., Miyamoto, T., Odawara, J., Ohkawa, Y., Semba, Y., Hayashi, M., Miyamura, K., Tanimoto, M., Yamamoto, K., Taniwaki, M. & Akashi, K., Nov 2017, In : Cancer Science. 108, 11, p. 2204-2212 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation

Suetsugu, K., Ikesue, H., Miyamoto, T., Shiratsuchi, M., Yamamoto-Taguchi, N., Tsuchiya, Y., Matsukawa, K., Uchida, M., Watanabe, H., Akashi, K. & Masuda, S., Mar 1 2017, In : International journal of hematology. 105, 3, p. 361-368 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2018

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)

Ishikawa, J., Matsumura, I., Kawaguchi, T., Kuroda, J., Nakamae, H., Miyamoto, T., Matsuoka, K. I., Shibayama, H., Hino, M., Hirase, C., Kamimura, T., Shimose, T., Akashi, K. & Kanakura, Y., May 1 2018, In : International journal of hematology. 107, 5, p. 535-540 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2016

Cord blood transplantation following reduced-intensity conditioning for adult-onset inherited hemophagocytic lymphohistiocytosis

Kuriyama, T., Kato, K., Sakamoto, K., Hayashi, M., Takashima, S., Mori, Y., Takenaka, K., Iwasaki, H., Teshima, T., Harada, N., Nagafuji, K., Miyamoto, T. & Akashi, K., Mar 15 2016, In : Internal Medicine. 55, 6, p. 667-671 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Ascites retention during mogamulizumab treatment in a patient with adult T-cell leukemia/lymphoma

Shima, T., Kamezaki, K., Higashioka, K., Takashima, S., Yoshimoto, G., Kato, K., Muta, T., Takenaka, K., Iwasaki, H., Miyamoto, T. & Akashi, K., Jan 1 2016, In : Internal Medicine. 55, 13, p. 1793-1796 4 p.

Research output: Contribution to journalArticle

Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis

Daitoku, S., Takenaka, K., Yamauchi, T., Yurino, A., Jinnouchi, F., Nunomura, T., Eto, T., Kamimura, T., Higuchi, M., Harada, N., Saito, N., Miyamoto, T., Iwasaki, H. & Akashi, K., Sep 1 2016, In : Experimental Hematology. 44, 9, p. 817-825.e3

Research output: Contribution to journalArticle

7 Citations (Scopus)
2018

A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

Takamatsu, H., Wee, R. K., Zaimoku, Y., Murata, R., Zheng, J., Moorhead, M., Carlton, V. E. H., Kong, K. A., Takezako, N., Ito, S., Miyamoto, T., Yokoyama, K., Matsue, K., Sato, T., Kurokawa, T., Yagi, H., Terasaki, Y., Ohata, K., Matsumoto, M., Yoshida, T. & 2 others, Faham, M. & Nakao, S., Nov 2018, In : British Journal of Haematology. 183, 4, p. 664-668 5 p.

Research output: Contribution to journalLetter

2 Citations (Scopus)

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan

Kawajiri-Manako, C., Sakaida, E., Ohwada, C., Miyamoto, T., Azuma, T., Taguchi, J., Mori, T., Hasegawa, Y., Kondo, T., Yujiri, T., Yoshimitsu, M., Imada, K., Kurahashi, S., Kahata, K., Ichinohe, T., Hirokawa, M., Atsuta, Y. & Nakaseko, C., Jun 2018, In : Biology of Blood and Marrow Transplantation. 24, 6, p. 1180-1186 7 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Correction to: Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study (International Journal of Hematology, (2018), 108, 5, (524-534), 10.1007/s12185-018-2505-4)

Matsue, K., Kumagai, K., Sugiura, I., Ishikawa, T., Igarashi, T., Sato, T., Uchiyama, M., Miyamoto, T., Ono, T., Ueda, Y., Kiguchi, T., Sunaga, Y., Sasaki, T. & Suzuki, K., Nov 1 2018, In : International journal of hematology. 108, 5, 1 p.

Research output: Contribution to journalComment/debate

Plerixafor for mobilization and collection of haematopoietic stem cells for autologous transplantation in Japanese patients with non-Hodgkin lymphoma: a randomized phase 2 study

Matsue, K., Kumagai, K., Sugiura, I., Ishikawa, T., Igarashi, T., Sato, T., Uchiyama, M., Miyamoto, T., Ono, T., Ueda, Y., Kiguchi, T., Sunaga, Y., Sasaki, T. & Suzuki, K., Nov 1 2018, In : International journal of hematology. 108, 5, p. 524-534 11 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2019

Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation, May 2019, In : American Journal of Hematology. 94, 5, p. E143-E146

Research output: Contribution to journalLetter

2 Citations (Scopus)
2018

Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in Japan

Muta, T., Miyamoto, T., Kamimura, T., Kanda, Y., Nohgawa, M., Ueda, Y., Iwato, K., Sasaki, O., Mori, T., Uchida, N., Iida, S., Fukuda, T., Atsuta, Y. & Sunami, K., Feb 1 2018, In : Acta Haematologica. 139, 1, p. 35-44 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2020

Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan

Yanada, M., Takami, A., Mizuno, S., Mori, J., Chou, T., Usuki, K., Uchiyama, H., Amano, I., Fujii, S., Miyamoto, T., Saito, T., Kamimura, T., Ichinohe, T., Fukuda, T., Okamoto, S., Atsuta, Y. & Yano, S., Jan 1 2020, In : International journal of hematology. 111, 1, p. 93-102 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2017

Comparison of Autologous and Unrelated Transplants for Cytogenetically Normal Acute Myelogenous Leukemia

Mizutani, M., Takami, A., Hara, M., Mizuno, S., Yanada, M., Chou, T., Uchiyama, H., Ohashi, K., Miyamoto, T., Ozawa, Y., Imataki, O., Kobayashi, N., Uchida, N., Kanamori, H., Kamimura, T., Eto, T., Onizuka, M., Tanaka, J., Atsuta, Y. & Yano, S., Sep 2017, In : Biology of Blood and Marrow Transplantation. 23, 9, p. 1447-1454 8 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
2020

Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab

on behalf of the Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation, Jan 1 2020, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

2016

A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia

Japan Society for Hematopoietic Cell Transplantation, Oct 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 10, p. 1836-1843 8 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)
2020

Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia

Kiyoi, H., Morris, J. D., Oh, I., Maeda, Y., Minami, H., Miyamoto, T., Sakura, T., Iida, H., Tuglus, C. A., Chen, Y., Dos Santos, C., Kalabus, J., Anderson, A., Hata, T., Nakashima, Y. & Kobayashi, Y., Jan 1 2020, (Accepted/In press) In : Cancer Science.

Research output: Contribution to journalArticle

Open Access
2019

Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Takamatsu, H., Yamashita, T., Kurahashi, S., Saitoh, T., Kondo, T., Maeda, T., Nakazawa, H., Murata, M., Narita, T., Kuroda, J., Hashimoto, H., Kawamura, K., Miyamoto, T., Honda, S., Ichinohe, T., Atsuta, Y. & Sunami, K., Mar 2019, In : Biology of Blood and Marrow Transplantation. 25, 3, p. 474-479 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)

Sunami, K., Matsumoto, M., Fuchida, S. I., Omoto, E., Takamatsu, H., Adachi, Y., Choi, I., Fujishima, N., Kiguchi, T., Miyamoto, T., Maeda, A., Suzumiya, J., Yamamura, R., Nagafuji, K., Nakazato, T., Kuroda, Y., Yujiri, T., Takamatsu, Y., Harada, M. & Akashi, K., Jan 1 2019, In : International Journal of Clinical Oncology.

Research output: Contribution to journalArticle

2017

Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation

Sugita, J., Miyamoto, T., Kawashima, N., Hatsumi, N., Anzai, N., Kaneko, H., Nara, M., Minauchi, K., Harada, M. & Teshima, T., Feb 1 2017, In : Bone Marrow Transplantation. 52, 2, p. 323-325 3 p.

Research output: Contribution to journalLetter

2020

Increasing Diluent Volume Decreases Bendamustine-Induced Venous Irritation without Reducing the Therapeutic Efficacy

Ishida, S., Morikawa, H., Watanabe, H., Tsuji, T., Sugio, T., Mori, Y., Miyamoto, T., Masuda, S., Akashi, K. & Egashira, N., Jan 1 2020, In : Biological & pharmaceutical bulletin. 43, 3, p. 488-492 5 p.

Research output: Contribution to journalArticle

Open Access
2016

Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102)

Ogiya, D., Shibayama, H., Nakatani, E., Ando, K., Suzuki, K., Kuroda, Y., Uchida, T., Maruyama, D., Matsumoto, M., Matsue, K., Iida, S., Terui, Y., Ri, M., Chou, T., Aotsuka, N., Tabata, S., Konishi, J., Ohashi, K., Shinagawa, A., Sugiura, I. & 6 others, Kuroda, J., Miyamoto, T., Ogura, M., Tobinai, K., Kanakura, Y. & Hotta, T., Jan 1 2016, In : [Rinsho ketsueki] The Japanese journal of clinical hematology. 57, 11, p. 2311-2318 8 p.

Research output: Contribution to journalArticle

Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis

Shimazaki, C., Fuchida, S. I., Suzuki, K., Ishida, T., Imai, H., Sawamura, M., Takamatsu, H., Abe, M., Miyamoto, T., Hata, H., Yamada, M. & Ando, Y., Jan 1 2016, In : International journal of hematology. 103, 1, p. 79-85 7 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2017

Mobilization of human immature hematopoietic progenitors through combinatory use of bortezomib and immunomodulatory drugs

Tochigi, T., Aoki, T., Kikushige, Y., Kamimura, T., Ito, Y., Shima, T., Yamauchi, T., Mori, Y., Yoshimoto, G., Kamezaki, K., Kato, K., Takenaka, K., Iwasaki, H., Akashi, K. & Miyamoto, T., Apr 1 2017, In : International journal of hematology. 105, 4, p. 423-432 10 p.

Research output: Contribution to journalArticle

Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation

Takamatsu, H., Takezako, N., Zheng, J., Moorhead, M., Carlton, V. E. H., Kong, K. A., Murata, R., Ito, S., Miyamoto, T., Yokoyama, K., Matsue, K., Sato, T., Kurokawa, T., Yagi, H., Terasaki, Y., Ohata, K., Matsumoto, M., Yoshida, T., Faham, M. & Nakao, S., Jan 1 2017, In : Annals of Oncology. 28, 10, p. 2503-2510 8 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)